Small Cap Feast

Small Cap Feast – 16 January 2019

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 916

Total number of AIM Companies trading: 846*
* As at 15 January 2019

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): 89*

Total number of NEX Growth Market Companies trading: 87*
* As at 15 January 2019

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): 139*

Total number of Standard List Companies trading: 130*
* As at 15 January 2019

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market (Specialist Funds)

The Global Sustainability Trust -aiming for attractive risk-adjusted returns by investing primarily in private market investments that are expected to have a positive environmental and social impact raising c.£200m. Due 31 Jan 2019.

Main Market (Standard)

Dev Clever Hldgs—Raising up to £700k gross.  The Group has invested over £600,000 in the last five years in developing proprietary software platforms and immersive frameworks to reshape the way its clients engage, acquire and retain their customers and employees through experience, rewards and incentives.  Mkt cap c. £3.7m

AIM

Circassia Pharma (CIR.L) – specialty pharmaceutical company focused on respiratory disease transferring from the Main Market. No funds being raised. Due 4 Feb.

Greenfields Petroleum (TSX-V:GNF)  production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD. Expected late January 2019.

Breakfast Buffet

Norcros (NXR.L) 186p £156m

Further South African acquisition. RAP Plumbing Supplies. Total consideration of up to South African Rand 215m approximately £12.1m.   FYApr18 rev c.£22.1m, EBITDA c.£1.9m. A further step in the Group’s growth strategy to expand its bathroom product portfolio and follows on from a number of very successful acquisitions, most recently that of Merlyn, and the sustained organic growth in South Africa.

The Group has continued to trade in line with the Board’s expectations in both the UK and South Africa since the announcement of its interim results on 15 Nov 2018.

FYMAr19E PE c.6.5x and yield over 4%.

 

EKF Diagnostics (EKF.L) 31.5p £143.4m

Trading update,  Adjusted EBITDA for the year ended 31 Dec 2018 is expected to be comfortably ahead of market expectations which had been upgraded during the period. In addition, cash generation in the second half has been very strong with net cash at the end of the year of £9.4m (31 December 2017: £7.0m net cash), which is after a £3.1m investment in Renalytix AI PLC and share buybacks of almost £0.9m.

FYDec18E rev £43.3m and PBT £6.65m.

 

BigDish (DISH.L) 1.85p £5m

BigDish, a food technology company that operates a yield management platform for restaurants, announced the Company’s successful launch in Bournemouth and completion of the BigDish app beta testing period.

BigDish app beta testing period completed.

The migration of Bournemouth restaurants from TablePouncer to BigDish began on 14 January 2019.

BigDish will be available in Bristol by the end of Jan 2019.

Redesign of the BigDish app has been completed targeting the UK market.

 

Serinus Energy (SENX.L) 15p £22.6m

The Company has confirmed that the Low Temperature Separation  unit and the Triethylene Glycol  unit  due for installation at its Moftinu gas plant in Romania have been loaded onto a freighter and have departed from Halifax, Canada, to Bremerhaven, Germany. Subject to weather in the Atlantic during shipment, the Units are expected to arrive in port approximately 6 to 10 days after departure.  The Units will then be trucked to the Moftinu site in Romania for final assembly, testing and commissioning.

 

SimplyBiz Group (SBIZ.L) 150p £115m

The independent provider of compliance and business services to financial advisers and financial institutions in the UK, announced that over 2,300 advisers have adopted Centra in the nine months since launch. Centra is a new end-to-end financial planning system designed to help advisers provide a quality, comprehensive and compliant financial planning journey for their clients.

Centra, which took over twelve months to develop, offers the Group’s members access to an integrated suite of tools covering the full range of adviser planning needs. The system includes; integrated goals-based financial planning tools, product research, suitability reports and a complete centralised investment process, backed by an independent investment committee.

 

Trackwise Designs (TWD.L) 97.5p £14.4m

FY Dec18 provider of specialist products using printed circuit technology.

The Company has seen strong growth in both its Radio Frequency and Improved Harness Technology divisions versus the prior year and profits for the year ended 31 Dec 2018 are expected to be in line with market expectations.

Whilst there have been some delays in ordering from IHT customers, and some uncertainty regarding the impact of Brexit, Trackwise continues to experience accelerating interest and demand for its unique IHT technology across the Company’s chosen markets of Aerospace, Automotive, Space and Industrial.

The equity funds raised at the time of the Company’s Admission to AIM in July 2018 are being invested in both manufacturing capability and capacity, together with sales and marketing resource.

 

Yellow Cake (YCA.L) 222p £168m

Quarterly update (to Dec 18) from the specialist company operating in the uranium sector with a view to holding physical uranium for the long term.

Steady improvement in the market fundamentals for U3O8, with the spot market price increasing by 25% from $22.85 /lb to $28.50 /lb since IPO on 5th July 2018

Value of underlying physical uranium (“U3O8”) held by Yellow Cake increased by 35% to $240.6 mm relative to acquisition cost of $178.2 mm

Total Yellow Cake holding of uranium of 8.44 million lb, acquired at an average cost of $21.10 /lb against a current spot price of $28.50 /lb 

NAV increased by 27% to £2.53 /share relative to IPO price of £2 per share

 

Somero (SOM.L) 295p £166m

Acquisition of the business assets of Line Dragon, LLC, a Pennsylvania based provider of concrete placing and hose dragging equipment to the concrete industry. The acquisition offers a unique opportunity to add to Somero’s broad portfolio of differentiated products. Line Dragon complements Somero’s SP-16 Concrete Line Placing & Pulling system, with the combined offering introducing innovative features to customers and expanding Somero’s customer relationships in this market segment.  In the year ended 31 Dec 2018 Line Dragon, LLC generated revenues of approximately $2m.  The transaction is expected to have a slight positive impact on 2019 earnings. Consideration -$2m in cash paid at closing along with on-going performance payments.  Trading: Strong growth drives revenue, EBITDA and cash ahead of expectations.  FYDec18E PE c.11x and yield c.6%.

 

BATM Advanced Comms (BATM.L) 46.4p £189.7m

The  provider of real-time technologies for networking solutions and medical laboratory systems, announces that Telco Systems, a wholly-owned high-end software development and design business within the Group’s Networking & Cyber division, has completed an upgrade of the Carrier Ethernet network of Kenya Education Network (KENET), the National Research and Education Network (NREN) of Kenya, from 10GE to 100GE.

As the NREN of Kenya, KENET provides high-speed Internet access and data centre services to member university campuses and research facilities across the country and interconnectivity with other NRENs around the world. KENET also provides shared cloud-based services, including co-location of servers, dedicated virtual servers for e-learning systems and video and web conferencing.

 

GetBusy (GETB.L) 34p £16.4 m

FYDec18 trading update.  Trading in H2 has continued at a similar pace. The Group expects to report that total revenue increased approximately 20% to £10.9m, on a constant currency basis. Adjusted EBITDA is expected to be in-line with expectations while cash as at 31 Dec 2018 was substantially better than expected at £2.5m, compared to £2.4m at 30 June 2018. Growth in the Group’s high quality recurring subscription revenue, at constant currency for the full year, was 22% with the growth rate in the UK accelerating to 17% following strong order intake and the transition to a pure subscription model.  Annualised Monthly Recurring Revenue at 31 Dec 2018 was £10.3m, an increase of 19% at constant currency.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.